Effect of vascular burden as measured by vascular indexes upon vascular dementia: a matched case-control study by Takahashi, Paul Y et al.
© 2012 Takahashi et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article  
which permits unrestricted noncommercial use, provided the original work is properly cited.
Clinical Interventions in Aging 2012:7 27–33
Clinical Interventions in Aging
Effect of vascular burden as measured by vascular 
indexes upon vascular dementia: a matched  
case-control study
Paul Y Takahashi
Casey R Caldwell
Paul V Targonski
Primary Care Internal Medicine, Mayo 
Clinic, Rochester MN, USA
Correspondence: Paul Y Takahashi 
Mayo Clinic, 200 First Street SW, 
Rochester, MN 55905, USA 
Tel +1 507 284 2511 
Email takahashi.paul@mayo.edu
Background: Vascular dementia (VaD) is a challenging illness that affects the lives of older 
adults and caregivers. It is unclear how multiple vascular risk factor exposures (polyvascular 
disease) affect VaD.
Purpose: To determine the relationship between multiple vascular risk exposures, as counted 
on an index in cases with VaD, compared with healthy age-/gender-matched controls.
Methods: This was a matched case-control study of subjects living in Olmsted County, MN 
with documented VaD. Controls were selected by gender and age within 3 years from those who 
did not have dementia. The exposures included a total index (eleven exposure factors) added 
together, along with indexes for cerebrovascular disease (two exposures), cardiovascular disease 
(four exposures), vascular disease (three exposures), and lifestyle (two exposures). Analysis 
used matched conditional univariable logistic regression for each index.
Results: A total of 1736 potential subjects were identified, and 205 subjects were diagnosed 
with VaD. There was a significant association of the total score index with an odds ratio of 
1.45 (95% confidence interval 1.21–1.74). The cerebrovascular index was also associated with 
VaD with an odds ratio of 12.18 (95% confidence interval 6.29–23.61). The cardiovascular and 
vascular indexes were also associated with VaD status. The lifestyle index was not associated 
with VaD.
Conclusion: The cumulative role of multiple vascular risk factors or diseases increased the risk 
of VaD, as noted by the total vascular index. The lifestyle index did not reveal any significant 
differences. Further work is required for evaluation of these indexes.
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Introduction
Vascular dementia (VaD) is a common condition that affected the lives of 594,000 
  people in the US in 2007.1 This number will grow as the population ages and 
as individuals live longer lives with vascular disease. VaD has two primary 
  components – namely, cerebrovascular disease and cognitive decline with neurologi-
cal deficits.2 Many assume the risk factors for VaD are the same as for stroke.3 This 
may not be true. The risk factors for VaD in the community are still not completely 
known, and there is some controversy over some traditional vascular risk factors 
such as smoking4 and hypertension.5 Although the individual risk factors still face 
controversy, one important entity that has not been fully explored is polyvascular 
disease. Polyvascular disease is the accumulation of multiple vascular diseases or risk 
factors, including the addition of coronary artery disease and peripheral artery disease. 
Individuals often have more than one vascular risk factor and can possess more than 
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one type of vascular disease. One might   hypothesize that 
the increase in vascular risk factor burden, or the increase 
in the number of vascular diseases, could potentially increase 
the risk of VaD.
In looking at stroke, a relationship between the number 
of strokes and the risk of VaD has been demonstrated.6 The 
continued burden of vascular insults upon the brain with 
multiple strokes increases risk for future dementia. What 
is not clear is the role of multiple risk factors upon the 
development of VaD. Do multiple risk factors or vascular 
diseases beyond the cerebrovascular system increase the risk 
of developing VaD? We hypothesize that an increase in the 
absolute number of risk factors will increase the risk of VaD. 
To address and answer this question we conducted a matched 
case-control study of individuals in Olmsted County, MN 
with documented VaD and controls without VaD.
Methods
Study design
This study utilized a retrospective matched case-control 
analysis of patients living within Olmsted County. The 
specific design and cohort have previously been described.7 
The study was reviewed and approved by the Mayo Clinic 
Institutional Review Board. The principles of the research 
followed the Declaration of Helsinki.8
Setting
All cases and controls in the study received care at the Mayo 
Clinic in Olmsted County. The Mayo Clinic is the largest 
health care provider in Olmsted County. The cases and 
  controls were obtained from the time period of 1994–2002. 
The timeline of the comorbid medical exposures occurred any 
time prior to the index date of diagnosis or matching.
Participants/cases
The investigators identified cases as patients with a   clinically 
documented diagnosis of definite VaD. The cases were 
determined from the inpatient and outpatient medical care 
records from 1994 to 2002. Personnel from the Mayo Clinic’s 
Health Science Research Department initially screened the 
electronic medical record for any one of the 40 diagnoses 
suggestive of dementia. The diagnostic information to make 
the determination of VaD was obtained from the medical 
history, neuroimaging studies, and clinical diagnosis from the 
medical record. The authors diagnosed VaD based upon the 
National Institute of Neurological Disorders and Stroke and the 
  Association Internationale pour la Recherche et l′Ensignement 
en Neurosicences (NINDS-AIREN)   criteria for definite VaD.2 
  Investigators using NINDS-AIREN   criteria have had   moderate 
to good agreement in   determining VaD.9
Controls
Controls were drawn and matched from the same general 
cohort as the cases. They were matched using the criteria 
described in the following section and had exposures evalu-
ated from the index date of the aforementioned matched 
control.
Exclusion criteria
Potential controls with the diagnosis of dementia from any 
cause prior to the index date were excluded from the study. 
Cases or controls that refused record review in accordance with 
Minnesota state law were also excluded from the study.
Matching
Cases were identified and matched 1:1 by age (±2 years), 
  gender, and their Mayo Clinic registration number. The 
controls were matched on age, due to the known effect of age 
upon the development of dementia.10 Matching by a registra-
tion number serves as a proxy for the amount of potential 
medical care previously received within the Mayo Clinic’s 
system, and this medical information is linked to the medical 
record.11 Matching age and the medical clinic number gives 
a similar length of medical care.
Population of Olmsted County
The US Census estimated Olmsted County’s population to be 
124,277 in 2000 during the time of recruitment.12 Individuals 
in Olmsted County possessed a higher educational level of 
38.9% with a bachelor degree, compared with 27.4% in the 
US. The demographic picture in Olmsted County reflected 
the following: 90.3% white, 4.3% Asian, and 2.7% black or 
African American.12
Exposure variables
Each exposure variable was counted singly to determine 
whether it was present in the cases or controls. To determine 
the vascular burden, the indexes were created. These indexes 
were not weighted and included all variables.
Demographic and lifestyle exposure  
variables
Age and gender were collected and matched for cases and 
controls. Educational years were determined based on the 
last year of education the subject attended. The lifestyle 
outcome variables were tobacco use ever, alcohol use ever, 
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and obesity. A dichotomous answer of yes or no was used for 
tobacco use. For the alcohol use, the comparisons were made 
in a similar manner with a yes or no answer.   Educational 
years and tobacco and alcohol use were obtained by self-
report from the subject prior to the index date of case or 
control determination. Obesity was defined as a body mass 
index of .30 kg/m2 using the National Heart, Lung, and 
Blood Institute’s definition of obesity.13 If the subject had 
a measured body mass index .30 kg/m2 in the preceding 
10 years, the subject was considered obese.
Comorbid health conditions
There were eight primary vascular comorbid medical condi-
tions that were considered for the indexes. Cerebrovascular 
disease was defined by the presence of two major comorbid 
illnesses of a previous stroke and/or transient ischemic attacks 
(TIAs). Cardiovascular risk factors included a diagnosis of 
myocardial infarction (MI), a history of anginal chest pain, 
a history of atrial fibrillation, and a diagnosis of congestive 
heart failure (CHF). The final two risk factors were hyper-
tension and diabetes. Hypertension was defined by Joint 
National Committee on Prevention, Detection, Evaluation, 
and Treatment of High Blood Pressure VII criteria as systolic 
blood pressure .140 mmHg.14 Systolic blood pressure was 
measured in the office by the clinical staff.
All information on both cases and controls were abstracted 
directly from the medical record, including physician notes, 
laboratory data, letters, and non-visit care information. These 
sources of information also included all information on 
hospitalizations and dismissal diagnoses from the hospital 
and outpatient clinic. The clinical team made the diagnosis 
while caring for the subject. The details of the Mayo Clinic 
medical record and how it was used in the study are noted 
in our previous manuscript.7 All information was abstracted 
by trained nurses, who were blinded to the study hypothesis. 
The information was subsequently recorded on an electronic 
spreadsheet (Excel, Redmond, WA). All of the exposures 
were classified as yes or no in a dichotomous fashion.
Cumulative index evaluation
After the aforementioned demographic, lifestyle, and comor-
bid exposure variables were collected, we created five dif-
ferent indexes to evaluate the potential role of all the risks 
together (total index), as well as specific indexes of lifestyle, 
cerebrovascular, cardiovascular, and vascular. These indexes 
were created based upon the common risk factors for stroke15 
and by including the common vascular and coronary artery 
disease risk factors. The answers were summed and reported 
as a continuous number to represent increasing vascular 
burden. The indexes are as follows:
•	 Lifestyle index: addition of history of “ever smoking,” 
“ever alcohol,” and obesity (score 0–3)
•	 Cerebrovascular index: addition of history of stroke and 
history of TIA (score 0–2)
•	 Cardiovascular index: addition of history of CHF, angina, 
atrial fibrillation, and MI (score 0–4)
•	 Vascular risk index: addition of history of “ever tobacco,” 
diabetes, and “ever hypertension” (score 0–3)
•	 Total index: addition of history of the following: “ever 
tobacco,” “ever alcohol,” obesity, stroke, TIA, CHF, 
angina, atrial fibrillation, MI, diabetes, and hypertension 
(score 0–11).
Data analysis
Simple descriptive statistics were calculated for demographic 
and comorbid medical illness data in the whole cohort, as 
well as in the cases and controls. The matching criteria 
were analyzed using a comparison between age and gender 
for cases and controls using parametric or nonparametric 
techniques as needed. The primary method of comparison 
between cases and controls utilized an odds ratio (OR) with 
95% confidence intervals (CI). The authors analyzed the 
data using conditional logistic regression for the matched 
case-control data. Statistical testing was carried out at the 
conventional two-tailed significance level of α = 0.05, cor-
rected for multiple comparisons as appropriate.
Results
Demographics
The initial characteristics of the cohort have been described 
previously.7 Briefly, 1736 potential subjects were identified 
using the initial evaluation from the medical record. After 
a review of the medical record, investigators identified 
205 cases of VaD, which were matched and paired with 
controls for 205 pairs. The 205 pairs included 121 pairs who 
were female and 84 pairs who were male. The overall mean 
age in the cohort was 81.9 years (standard deviation [SD] 
7.79 years). The average educational achievement was 12.3 
years (SD 3.25 years). The full demographic and descriptive 
information of the overall cohort is noted in Table 1.
The ORs for the individual components of the indexes 
reveal the largest ORs for cerebrovascular disease. Stroke 
had the highest OR of 20.00 (95% CI 8.81–45.41), with TIAs 
having the second-highest OR of 5.90 (95% CI 3.02–11.53). 
Atrial fibrillation and diabetes were the only other comorbid 
medical conditions to have a significantly higher OR of 
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exposure in the cases compared with the controls. The ORs 
for all of the exposures are noted in Table 2.
The ORs for the cumulative index scores for all of 
the indexes were statistically significant, except the lifestyle 
index. A majority of the indexes were statistically significant, 
in spite of the generally insignificant findings for the indi-
vidual exposure variables. The OR of the total score index 
was 1.45 (95% CI 1.21–1.74). This index took into account 
all of the exposure variables. The index with the largest OR 
was the cerebrovascular index with an OR of 12.18 (95% CI 
6.29–23.61). The OR of the cardiovascular index was 1.39 
(95% CI 1.14–1.70), and the vascular index had a similar OR. 
The full findings of the five indexes are noted in Table 3.
Discussion
This study sought to determine the relationship between 
increasing numbers of vascular risk factors and the presence 
of VaD. We found that as a subject suffered an increasing 
number of vascular risks and comorbid illnesses, the risk of 
possessing VaD increased. The risk of VaD increased by 
45% for each additional factor, using the total risk index. 
Thus, the risk of VaD almost doubled for every two vascular 
Table 1 Demographic overview of cases of VaD and controls in 205 matched pairs
Overall (n = 410) VaD cases (n = 205) Controls (n = 205)
Demographic
Male (%) 168 (41.0) 84 (41.0) 84 (41.0)
Age in years (SD) 81.9 (7.79) 82.1 (7.73) 81.6 (7.85)
Education in years (SD) 12.3 (3.25) 12.0 (3.35) 12.6 (3.13)
Body mass index kg/m2 (SD) 26.2 (5.02) 25.8 (4.50) 26.5 (5.40)
Obese Y/N (%) 175 (53.4) 76 (51.4) 99 (55.0)
Lifestyle
Ever alcohol use (%) 394 (76.9) 149 (74.9) 154 (79.0)
Ever tobacco use (%) 223 (55.5) 112 (55.7) 111 (55.2)
Comorbid health conditions
history of stroke (%) 148 (37.0) 133 (65.8) 15 (7.6)
history of TIA (%) 80 (20.0) 66 (32.7) 14 (7.1)
history of ChF (%) 88 (21.8) 60 (29.3) 28 (14.1)
history of angina (%) 130 (32.2) 70 (34.1) 60 (30.3)
History of atrial fib (%) 88 (21.8) 58 (28.3) 30 (15.1)
history of previous MI (%) 78 (19.3) 41 (20.0) 37 (18.6)
history of hypertension (%) 291 (72.9) 161 (80.1) 130 (65.7)
history of diabetes (%) 101 (24.7) 64 (31.2) 37 (18.1)
Reprinted from Takahashi PY, Caldwell CR, Targonski PV. Effect of alcohol and tobacco use on vascular dementia: a matched case control study. Vasc Health Risk Manag. 
2011;7:685–691, with permission from Dove Medical Press Ltd.7
Abbreviations: CHF, congestive heart failure; fib, fibrillation; MI, myocardial infarction; SD, standard deviation; TIA, transient ischemic attack, VaD, vascular dementia.
Table 2 Univariable exposure odds ratios for cases of vascular dementia compared with controls in 205 matched pairs
Odds ratio 95% CI P-value
Lifestyle
Obese Y/N 0.72 0.42–1.23 0.23
Ever alcohol use 0.80 0.49–1.31 0.38
Ever tobacco use 1.00 0.66–1.52 1.00
Comorbid health conditions
history of stroke 20.00 8.81–45.41 ,0.001*
history of TIA 5.90 3.02–11.53 ,0.001*
history of ChF 1.08 0.62–1.89 0.78
history of angina 1.22 0.79–1.88 0.38
History of atrial fib 2.50 1.44–4.32 0.001*
history of previous MI 1.11 0.66–1.87 0.69
history of hypertension 0.87 0.59–1.29 0.49
history of diabetes 2.00 1.26–3.17 0.003*
Note: *Indicates significant value.
Reprinted from Takahashi PY, Caldwell CR, Targonski PV. Effect of alcohol and tobacco use on vascular dementia: a matched case control study. Vasc Health Risk Manag. 
2011;7:685–691, with permission from Dove Medical Press Ltd.7
Abbreviations: CHF, congestive heart failure; CI, confidence interval; fib, fibrillation; MI, myocardial infarction; TIA, transient ischemic attack.
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illnesses or exposures. This was the important finding of 
our study. These findings are impressive and novel because 
they can potentially help a clinician to risk-stratify a patient 
for the development of VaD. Of the individual indexes, 
cerebrovascular disease had the highest OR at 12.18 (95% 
CI 6.29–23.61). The relationship between stroke and VaD 
would be expected, given the diagnostic criteria for VaD.16 
In previous studies, there was also a relationship between 
cerebrovascular symptoms and cognitive decline, as seen 
with the large population-based third National Health and 
Nutrition Examination Survey.17 The important findings of 
a vascular load of risk factors are of particular importance 
in patients without a diagnosis of stroke or TIA.
The relationship between a functional index or a combi-
nation of risk factors and VaD has been reported in a small 
number of studies. The Charlson Comorbidity Index18 has 
been evaluated in older adults with VaD and other forms of 
dementia, specifically Alzheimer’s disease (AD). In patients 
with AD, there were increased risks of previous hospitaliza-
tions and fractures with increased comorbid medical illness 
in patients with AD, compared with a matched control.19 In 
a separate study, a group of patients with cognitive decline 
tended to have more chronic health problems than people with 
intact memory.20 Comparing the comorbid status of patients 
with VaD compared with AD or mixed dementia is also 
important. Patients with VaD were sicker than AD patients 
and had more comorbid illness and lower functional status.21 
The frailty index proposed by Rockwood and Mitnitski22,23 
is largely based on the accumulation of multiple comorbid 
diseases. As patients developed more diseases, the patient’s 
functional status started to decline. Thus, indirectly, patients 
with vascular disease have more comorbid illnesses and are 
likely to be frailer than others without VaD. The comorbid 
illnesses discussed previously are largely nonspecific and 
do not necessarily reflect polyvascular disease. Our study is 
unique because it specifically targets vascular illnesses and 
risk factors. However, the concepts may be similar, with 
an increase in comorbid conditions or vascular risk factors 
leading to an increase in the frequency of VaD.
The initial combinations of other vascular risks beyond 
cerebrovascular disease, including cardiovascular and vas-
cular, did reveal that these measures have some association 
with VaD. The association of vascular illness and VaD goes 
beyond the cerebrovascular system. Of the individual risk 
factors, atrial fibrillation had the highest risk of VaD with 
an OR of 2.50 (95% CI 1.44–4.32). Atrial fibrillation has 
had an association with dementia in previous studies.24,25 In 
spite of the remaining three cardiovascular risk factors being 
nonsignificant statistically, the cardiovascular index was 
significant with an OR of 1.39 (95% CI 1.14–1.70). Thus, 
the cumulative effect of cardiovascular disease is shown. In 
a similar fashion, the vascular index had a significant rela-
tionship with VaD, with diabetes as the only individually 
significant exposure variable. The lifestyle index did not 
show an association with VaD cases. This may reflect the 
opposite effects of smoking and alcohol use and also reflects 
a lack of significance of the individual components of the 
index. These indexes have not been validated on a population-
based cohort and may merit future studies to develop scoring 
systems that can be applied to identify high-risk older adults 
at risk for developing VaD.
The concept of polyvascular disease is important for clini-
cians to consider. Patients face vascular diseases in not only 
the area of concern like the heart but also the cerebrovascular 
system and the rest of the body. The concept that multiple 
vascular beds are affected by a common genetic, lifestyle, 
and exposure process has been emerging. In the REACH 
(Reduction of Atherothrombosis for Continued Health) study, 
77% of patients had single vascular comorbidity (coronary 
artery disease, cerebrovascular disease, vascular disease) 
Table 3 Univariate analysis of five different cumulative indexes for 205 matched pairs of vascular dementia cases and healthy controls
Odds ratio Lower 95% CI Upper 95% CI P-value
Cumulative index
Lifestyle indexa 0.82 0.61 1.11 0.20
Cerebrovascular indexb 12.18 6.29 23.61 ,0.001*
Cardiovascular indexc 1.39 1.14 1.7 0.0013*
Vascular indexd 1.50 1.16 1.94 0.0022*
Total score indexe 1.45 1.21 1.74 ,0.001*
Notes: aLifestyle index; risk factors of (1) ever tobacco, (2) ever alcohol, (3) obesity (score 0–3); bcerebrovascular index; risk factors of (1) history of stroke, (2) history of 
TIA (score 0–2); ccardiovascular index; risk factors of (1) history of congestive heart failure, (2) history of angina, (3) history of atrial fibrillation, (4) history of myocardial 
infarction (score 0–4); dvascular index; risk factors of (1) ever tobacco, (2) history of diabetes, (3) history of hypertension (score 0–3); etotal score index; risk factors of   
(1) ever tobacco, (2) ever alcohol, (3) obesity, (4) history of stroke, (5) history of transient ischemic attacks, (6) history of congestive heart failure, (7) history of angina, 
(8) history of atrial fibrillation, (9) history of myocardial infarction, (10) history of diabetes, (11) history of hypertension (score 0–11). *Significant.
Abbreviations: CI, confidence interval; TIA, transient ischemic attack.
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and 22.8% had polyvascular disease (more than one). The 
subjects with polyvascular disease had higher rates of car-
diovascular death/nonfatal MI/nonfatal stroke with an OR of 
1.63 (95% CI 1.45–1.83).26 The role of polyvascular disease 
and the development of VaD still remain to be fully answered. 
The results of the REACH study shed some light on the role 
of multiple vascular illnesses or risks with the development 
of VaD. The results of our study are novel; however, they 
fit within the theme of multiple vascular illnesses having a 
higher risk of major vascular events.
There are multiple strengths of this study design and 
approach, which enhance its utility in determining the role 
of multiple vascular illnesses for the development of VaD. 
The matched case-control design allowed for a stronger 
analysis, compared with a non-matched case-control design. 
This design allowed for removal of the confounding factors 
of age, gender, and exposure to the medical system. The 
cases were defined based upon strict, standardized criteria 
after the initial preliminary case finding using the electronic 
record. However, the diagnosis of VaD was not based upon 
pathology diagnosis. The exposures were determined by 
nurse abstraction and medical record review. There can 
always be concerns with miscoded information or missing 
information using medical abstraction. The accuracy of 
electronic information can depend on the type of information 
being abstracted from the chart. Nurse abstraction is likely 
to be more accurate than electronic means alone.27 In stroke 
care and evaluation, there appears to be excellent agreement 
of abstracted information on stroke care using abstractors.28 
Despite all measures to reduce missing information, some 
missing or misinterpreted information from the medical chart 
still remained.
The weaknesses of the study included many of the inher-
ent challenges of using a case-control study. The case-control 
study can provide accurate information in a timely fashion 
and is frequently used in public health.29 The case-control 
study was the most practical study design because VaD is 
relatively uncommon compared with AD. The inherent chal-
lenges of the case-control study included the reporting of the 
exposures from patients and recording those exposures in 
the medical chart. Biometric information and demographic 
information is often recorded in a reproducible manner that 
does not rely upon self-report. Lifestyle exposures are more 
difficult because they rely upon self-report. The self-report of 
alcohol30,31 and other lifestyle issues like tobacco use affects 
the exposures in the study, as some subjects may under-report 
their exposures. Further, information on amount and time 
of tobacco and alcohol exposure became more sporadic; 
thus, this information was not reported. The diagnosis of 
medical conditions was standardized in the study; however, 
these diagnoses were often made clinically and subject to 
improper diagnoses or omission. Lastly, we used a simple 
count method and not a weighted scoring mechanism. This 
method does not allow for a differential weight for each vari-
able. Despite the limitations, this study provides important 
insights into the relationship of polyvascular disease and 
VaD status.
Conclusion
This matched case-control study demonstrates the relation-
ship between increasing incremental vascular risk exposures 
and VaD status. The total index of all exposures had a positive 
relationship to VaD status, as did the cerebrovascular index, 
cardiovascular index, and vascular index. Lifestyle exposures 
and the lifestyle index did not have a relationship with VaD. 
Further work will be required to evaluate multiple vascular 
diseases in different populations and to integrate this potential 
knowledge within clinical practice.
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